Skip to main content
. 2019 Dec 18;52(2):594–603. doi: 10.4143/crt.2019.493

Fig. 3.

Fig. 3.

Progression-free survival (according to Response Evaluation Criteria in Solid Tumor [RECIST] v1.1 and immune-modified RECIST [imRECIST]) and overall survival. OS, overall survival; CI, confidence interval; PFS, progression-free survival.